All News

Guided imagery decreased stress and relieved anxiety in patients who used the technique before and after radiation therapy for breast cancer, according to a study presented during a poster session at the San Antonio Breast Cancer Symposium.

One of the most visible side effects of chemotherapy is hair loss—a problem so distressing that some patients refuse treatment to avoid going bald.Studies have suggested that cooling the scalp during and immediately after treatment may help reduce hair loss. When the skin is cold, less blood flows to hair follicles, reducing their exposure to the drugs. One product, the Penguin Cold Cap System (manufactured by Medical Specialties of California UK), is billed as preventing hair loss in 80 percent of patients.

Women diagnosed with breast cancer could lower their risk of recurrence by cutting back on alcohol consumption, a new analysis suggests. Obesity itself is known to raise the risk of breast cancer, but a study described Thursday suggests that, after diagnosis, women who are overweight may fare worse than their normal-weight peers.

Studies have shown that Avastin, an angiogenesis inhibitor, has delayed disease progression in breast cancer patients, but a survival benefit has yet to be seen.

Two Komen advocates talk about their work on the local and global scenes

Screening with breast MRI may be particularly useful in patients with a high-risk lesion who also have a family history of breast cancer, according to a preliminary analysis of research presented at a poster session on Saturday at the San Antonio Breast Cancer Symposium.

Every year, CURE invites one advocate who is attending the San Antonio Breast Cancer Symposium to serve as a guest blogger. This year, readers will be hearing from Bev Parker, PhD, a 24-year breast cancer survivor who is attending the symposium for the seventh year.

Recap of the 2008 San Antonio Breast Cancer Symposium.

By identifying women at low risk for breast cancer, resources can be redirected to high-risk women, thus lowering the incidence of breast cancer, said Jack Cuzick, PhD, on Wednesday during an educational session about breast cancer prevention. It’s a goal, he said, that should be achievable within 10 to 20 years.

Women taking bisphosphonates have less chance of developing invasive breast cancer than women who don’t take the bone-strengthening drugs.